SAN FRANCISCO, Dec. 23 /PRNewswire/ -- Jennerex Biotherapeutics, a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced that management will present at the following upcoming investor conferences.
CONTACT: Jennifer Cook Williams of Cook Williams Communications, Inc.,
+1-360-668-3701, jennifer@cwcomm.org, for Jennerex Biotherapeutics
Web site: http://www.jennerex.com/
